[go: up one dir, main page]

AR053678A1 - Compuestos farmaceuticamente activos, su manufactura, composiciones que los contienen y su uso - Google Patents

Compuestos farmaceuticamente activos, su manufactura, composiciones que los contienen y su uso

Info

Publication number
AR053678A1
AR053678A1 ARP060100490A ARP060100490A AR053678A1 AR 053678 A1 AR053678 A1 AR 053678A1 AR P060100490 A ARP060100490 A AR P060100490A AR P060100490 A ARP060100490 A AR P060100490A AR 053678 A1 AR053678 A1 AR 053678A1
Authority
AR
Argentina
Prior art keywords
compositions
degree
manufacture
contain
active compounds
Prior art date
Application number
ARP060100490A
Other languages
English (en)
Inventor
Maurice Sydney Newton
Nigel Peter Rhodes
Alexis John Toft
Original Assignee
Ineos Silicas Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ineos Silicas Ltd filed Critical Ineos Silicas Ltd
Publication of AR053678A1 publication Critical patent/AR053678A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/02—Magnesium compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Iron (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Una sustancia usada como medicamento, que comprende un compuesto metálico solido mixto de formula (1): MII1-aMIIIaObAn- c.zH2= donde MII es al menos un metal bivalente, MIII es al menos un metal trivalente; An- es al menos un anion n-valente; 2+a= 2b+sumatoriacn y sumatoriacn <0.9S. La sustancia puede ser hecha calentando a una temperatura de 200 degree C a 600 degree C, preferiblemente de 250 degree C a 500 degree C, una sustancia que comprende un compuesto de formula (2): MII1-xMIII(OH)2An-y.mH2O donde MII es al menos un metal bivalente; MIII es al menos un metal trivalente; An- es al menos un anion n-valente; x= sumatoriayn 0<x<=0.5,0<y<=1y 0<m<= 10.
ARP060100490A 2005-02-10 2006-02-10 Compuestos farmaceuticamente activos, su manufactura, composiciones que los contienen y su uso AR053678A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0502787.5A GB0502787D0 (en) 2005-02-10 2005-02-10 Pharmaceuticlly active compounds, their manufacture, compositions containing them and their use

Publications (1)

Publication Number Publication Date
AR053678A1 true AR053678A1 (es) 2007-05-16

Family

ID=34356109

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP060100490A AR053678A1 (es) 2005-02-10 2006-02-10 Compuestos farmaceuticamente activos, su manufactura, composiciones que los contienen y su uso
ARP160103488A AR106699A2 (es) 2005-02-10 2016-11-15 Compuestos farmacéuticamente activos, su manufactura, composiciones que los contienen y su uso

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP160103488A AR106699A2 (es) 2005-02-10 2016-11-15 Compuestos farmacéuticamente activos, su manufactura, composiciones que los contienen y su uso

Country Status (20)

Country Link
US (2) US20080206358A1 (es)
EP (2) EP1850859B1 (es)
JP (2) JP5328157B2 (es)
KR (3) KR101491531B1 (es)
CN (2) CN101115490B (es)
AR (2) AR053678A1 (es)
AU (1) AU2006213922B2 (es)
BR (1) BRPI0606923B1 (es)
CA (1) CA2597124C (es)
ES (1) ES2599152T3 (es)
GB (1) GB0502787D0 (es)
IL (1) IL184448A (es)
MX (1) MX2007009688A (es)
MY (1) MY150070A (es)
NO (2) NO341846B1 (es)
NZ (1) NZ556600A (es)
RU (1) RU2420297C2 (es)
TW (1) TWI461201B (es)
WO (1) WO2006085079A2 (es)
ZA (1) ZA200706160B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9720061D0 (en) * 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en) * 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) * 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
GB0913525D0 (en) * 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) * 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
GB201005931D0 (en) 2010-04-09 2010-05-26 Isis Innovation Immune modulation
US9649335B1 (en) * 2016-03-30 2017-05-16 Baylor University Intravenous administration of an oxygen-enabled fluid
EP3873490A1 (en) 2018-10-25 2021-09-08 EirGen Pharma Ltd. Methods of treatment with mixed metal compounds
WO2022081950A1 (en) * 2020-10-17 2022-04-21 David Anderson Formulation and noncovalent stabilization of olivetolic acid derivatives
RU2758671C1 (ru) * 2020-12-08 2021-11-01 Федеральное государственное бюджетное учреждение науки Институт физики прочности и материаловедения Сибирского отделения Российской академии наук (ИФПМ СО РАН) СПОСОБ ПОЛУЧЕНИЯ НАНОСТРУКТУРНЫХ ДВОЙНЫХ ГИДРОКСИДОВ НА ОСНОВЕ АЛЮМИНИЯ И ЩЕЛОЧНОЗЕМЕЛЬНЫХ МЕТАЛЛОВ, ТАКИХ КАК МАГНИЙ ИЛИ КАЛЬЦИЙ, ОБЛАДАЮЩИХ СВОЙСТВОМ ПОВЫШАТЬ pH КЛЕТОЧНОЙ СРЕДЫ, И НАНОСТРУКТУРЫ, ПОЛУЧЕННЫЕ ДАННЫМ СПОСОБОМ

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2838930C2 (de) * 1978-09-07 1980-07-03 Chemische Werke Huels Ag, 4370 Marl Wäßriges Behandlungsmittel für Holz und Holzwerkstoffe und dessen Verwendung
US4514389A (en) * 1981-05-06 1985-04-30 Kyowa Chemical Industry Co. Ltd. Gastric antacid and method for controlling pH of gastric juice
JPS606619A (ja) * 1983-06-27 1985-01-14 Kyowa Chem Ind Co Ltd 鉄分欠乏症処置剤及びその製法
US4566986A (en) * 1984-08-31 1986-01-28 Waldmann John J Flocculating agents and processes for making them
US5153156A (en) * 1989-04-18 1992-10-06 Aristech Chemical Corporation Process for making efficient anionic clay catalyst, catalysts made thereby, and method of making isophorone
US5246899A (en) * 1991-08-16 1993-09-21 Amoco Corporation Simplified preparation of hydrotalcite-type clays
NL9201907A (nl) * 1992-11-02 1994-06-01 Tno Peristaltisch mengende reactor en peristaltische kleppenpomp.
US5506248A (en) * 1993-08-02 1996-04-09 Bristol-Myers Squibb Company Pharmaceutical compositions having good dissolution properties
GB9506126D0 (en) * 1995-03-25 1995-05-10 Johnson Matthey Plc Pharmaceutical composition and method
GB9720061D0 (en) * 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
US6720005B1 (en) * 2000-07-07 2004-04-13 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Coated, platform-generating tablet
US20040247696A1 (en) * 2001-07-05 2004-12-09 Antelman Marvin S. Methods of using electron active compounds for managing conditions afflicting mammals
US20040161474A1 (en) * 2002-05-24 2004-08-19 Moerck Rudi E. Rare earth metal compounds methods of making, and methods of using the same
JP4348426B2 (ja) * 2002-08-29 2009-10-21 独立行政法人産業技術総合研究所 高選択性脱リン剤及びその製造方法
US7381428B2 (en) * 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
WO2005027876A1 (en) * 2003-08-28 2005-03-31 Ranbaxy Laboratories Limited Pharmaceutical compositions of benzimidazole and processes for their preparation
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate

Also Published As

Publication number Publication date
IL184448A0 (en) 2007-10-31
KR101491531B1 (ko) 2015-03-09
BRPI0606923B1 (pt) 2019-06-18
JP2013209401A (ja) 2013-10-10
CA2597124C (en) 2015-11-24
RU2007133720A (ru) 2009-03-20
TW200640476A (en) 2006-12-01
NO20074504L (no) 2007-11-12
AU2006213922B2 (en) 2011-09-29
EP1850859B1 (en) 2016-07-20
RU2420297C2 (ru) 2011-06-10
MY150070A (en) 2013-11-29
AU2006213922A1 (en) 2006-08-17
US20120093943A1 (en) 2012-04-19
EP1850859A2 (en) 2007-11-07
US20080206358A1 (en) 2008-08-28
TWI461201B (zh) 2014-11-21
JP5328157B2 (ja) 2013-10-30
CN101115490A (zh) 2008-01-30
BRPI0606923A2 (pt) 2009-12-01
ZA200706160B (en) 2009-02-25
AR106699A2 (es) 2018-02-07
NO341846B1 (no) 2018-02-05
NZ556600A (en) 2010-02-26
EP3120855A1 (en) 2017-01-25
CN101115490B (zh) 2015-12-09
GB0502787D0 (en) 2005-03-16
KR20140066756A (ko) 2014-06-02
KR20130121186A (ko) 2013-11-05
ES2599152T3 (es) 2017-01-31
KR20070082918A (ko) 2007-08-22
CN105412150B (zh) 2019-05-17
MX2007009688A (es) 2008-01-22
CN105412150A (zh) 2016-03-23
CA2597124A1 (en) 2006-08-17
JP2008530065A (ja) 2008-08-07
NO20171769A1 (no) 2007-11-12
IL184448A (en) 2014-12-31
WO2006085079A3 (en) 2006-12-14
AU2006213922A2 (en) 2006-08-17
WO2006085079A2 (en) 2006-08-17

Similar Documents

Publication Publication Date Title
AR053678A1 (es) Compuestos farmaceuticamente activos, su manufactura, composiciones que los contienen y su uso
CL2011000504A1 (es) Compuestos derivados de piridin-4-il-tiazol-2il-amida 2-amida-pirrolidin-1,2-dicarboxilico, inhibidores de quinasa de fosfatidil-inositol-3; composicion farmaceutica que comprende a uno de los compuestos; y uso de los compuestos en la preparacion de un medicamento para el tratamiento del cancer.
CY1113011T1 (el) Νεα κρυσταλλικη μορφη v της αγομελατινης, μεθοδος παρασκευης αυτης και φαρμακευτικες συνθεσεις που περιεχουν αυτην
MX379353B (es) Compuesto de piperidina tipo quinoxalina sustituida y uso de los mismos.
NI201100048A (es) Aminotriazolopiridinas y su uso como inhibidores de la cinasa.
CR10095A (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
BRPI0510177B8 (pt) composto, composição farmacêutica e uso do mesmo
EA201791254A1 (ru) Кристаллические сольваты и комплексы производных (1s)-1,5-ангидро-1-c-(3-((фенил)метил)фенил)-d-глюцитола с аминокислотами в качестве ингибиторов sglt2 для лечения диабета
CL2004000969A1 (es) Compuestos derivados de alquilarilo; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento y/o profilaxis de la obesidad y trastornos relacionados.
UY29886A1 (es) Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones
PE20051131A1 (es) COMPOSICIONES ANTIPERSPIRANTES CON pH ELEVADO DE EFICACIA MEJORADA
EA200700501A1 (ru) Композиция (варианты) и способ для лечения гиперпролиферативных процессов, способ лечения рака (варианты) и способ получения твёрдой дисперсии вещества
EA200601274A1 (ru) Новая кристаллическая форма iii агомелатина, способ её получения и фармацевтические композиции, которые её содержат
BR0309343A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
EA201000089A1 (ru) Применение гомо- и сополимеров для стабилизации составов активных ингредиентов
BR0309342A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
CU20120084A7 (es) Compuestos derivados de triazolopiridina sustituidos como inhibidores de la quinasa mps-1 y compuestos intermediarios para su preparación
AR067824A1 (es) Compuestos de acido boronico y ester boronico inhibidores de la proteasoma, composiciones farmaceuticas que los contienen y usos de los mismos para el tratamiento del cancer.
BRPI0915084B8 (pt) composto, e, composição farmacêutica
ECSP078062A (es) Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen
NZ714558A (en) Formulation comprising a hypolipidemic agent
EA201001196A1 (ru) Соединения 4-пиридинона и их применение для лечения рака
BRPI0408353A (pt) composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto
BRPI0714885B8 (pt) compostos terapêuticos e seu uso
PE20212103A1 (es) Mezclas y composiciones que comprenden 5-fluoro-4-imino-3-metil-1-tosil-3,4-dihidropirimidin-2-ona, y metodos de uso de los mismos

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee